skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I would like your comments on FLGT's Quarter and future guidance. It looked like a blowout to me but the market reaction seems quite muted at the time I am writing this. Guidance is also impressive, calling for revenues of $800m in 2021 a 90% yoy increase after an impressive 2020. FLGT has great margins of around 50%, so 4X next years sales tells us its trading around 8 times next year’s expected earnings….8X forward P/E is what you might expect on a sleepy, slow-growth stock. What am I missing, or is this simply being ignored on a bad market day? A Buy?
Read Answer Asked by Scott on March 06, 2021
Q: I see ABCL is taking it on the chin today down 12% as I type this question. Since about January 1, 2021 I have been considering selling my NVTA and putting the money in ABCL but have done nothing to date. (Procrastination is sometimes the key to success)! NVTA weighting is 1.5%. 2 Questions...
Do you think ABCL has better long term prospects than NVTA and would you be interested in ABCL at +/- $31.50 USD? Or do you think I should use the basket approach and hold both?
Thanks,
Jim
Read Answer Asked by James on March 05, 2021
Q: Could you please comment on VHI's latest licensing deal.
Thanks as always.

VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a multi-year large-scale licensing transaction of recently acquired subsidiary Intouch with Health’s (“Intouch”) Synopsis product with South Tees Hospitals NHS Foundation Trust (the “Trust” or “South Tees”).

This transaction is among VitalHub’s largest to-date, comprising a 5-year licensing contract for the Company’s proprietary, award-winning Synopsis platform. From initial questionnaire through to post-operative outcomes, Synopsis provides the necessary tools to enable hospitals to manage the entire pre-operative assessment process digitally – removing paper trails, increasing data security, and delivering significant organizational and economic benefits.
Read Answer Asked by karl on March 03, 2021
Q: Hello Peter & Team,

I have been watching ASG for some time as from what I read, I felt they had real potential with the innovative devices they invented for minimally-invasive surgery and regenerative medicine for relief of aging back issues. A big market to say the least.

I know they are small right which makes them risky and the medical sector is a very hard nut to crack but, they have seen shares increase in value 53% since Feb 6th and at one point today got to $1.04 before settling back at $0.78.

I read the Feb 9 2021 press release regarding their common shares now trading on the OTCQB Venture Market (the "OTCQB Venture"), a US trading platform that is operated by the OTC Markets Group in New York which will enable US-based investors to seamlessly get involved in Aurora. It appears to me this announcement directly corresponds with the recent gains. Am I naïve in thinking this was a big announcement? Or are my observations valid?

I did notice a 55% increase ($0.25 - $0.45) Dec 11th through Feb 5th which was before this announcement was made. And as of late, trading volume has gone through the roof - close to 338,000 shares with the average volume being just over 47,000.

Am I looking for what I want to see in order to convince myself to pull the trigger on a trade? Or are these facts indeed significant indicators there may be something here to be serious about? Would this be an indication there may be a take over bid being looked at?

If there are any other insights you feel may be valuable, would be greatly appreciated.

thanks for all you do

gm
Read Answer Asked by Gord on February 23, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!